Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials
Spiess, Birgit, Rinaldetti, Sébastien, Naumann, Nicole, Galuschek, Norbert, Kossak-Roth, Ute, Wuchter, Patrick, Tarnopolscaia, Irina, Rose, Diana, Voskanyan, Astghik, Fabarius, Alice, Hofmann, Wolf-KaVolume:
14
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0214305
Date:
March, 2019
File:
PDF, 1.61 MB
english, 2019